2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
|
|
|
- Jeffery Howard
- 7 years ago
- Views:
Transcription
1 Measure #440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time Pathologist to Clinician National Quality Strategy Domain: Communication and Care Coordination 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) (including in situ disease) in which the pathologist communicates results to the clinician within 7 days of biopsy date INSTRUCTIONS: This measure is to be reported each time a biopsy is performed during the performance period. It is anticipated that eligible clinicians providing the pathology services for procedures will submit this measure. Measure Reporting: The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. DENOMINATOR: All pathology reports generated by the Pathologist/Dermatopathologist consistent with cutaneous basal cell carcinoma or squamous cell carcinoma (to include in situ disease) Denominator Criteria (Eligible Cases): Diagnosis for cutaneous basal carcinoma or squamous cell carcinoma (ICD-10-CM): C44.01, C44.02, C44.111, C44.112, C44.119, C44.121, C44.122, C44.129, C44.211, C44.212, C44.219, C44.221, C44.222, C44.229, C44.310, C44.311, C44.319, C44.320, C44.321, C44.329, C44.41, C44.42, C44.510, C44.511, C44.519, C44.520, C44.521, C44.529, C44.611, C44.612, C44.619, C44.621, C44.622, C44.629, C44.711, C44.712, C44.719, C44.721, C44.722, C44.729, C44.81, C44.82, C44.91, C44.92, D04.0, D04.10, D04.11, D04.12, D04.20, D04.21, D04.22, D04.30, D04.39, D04.4, D04.5, D04.60, D04.61, D04.62, D04.70, D04.71, D04.72, D04.8, D04.9 AND Patient procedure during the performance period (CPT): 88304, AND NOT DENOMINATOR EXCLUSION: Pathologists/Dermatopathologists providing a second opinion on a biopsy: G9784 NUMERATOR: Number of final pathology reports diagnosing cutaneous basal cell carcinoma or squamous cell carcinoma (to include in situ disease) sent from the Pathologist/Dermatopathologist to the biopsying clinician for review within 7 business days from the time when the tissue specimen was received by the pathologist 1 of 6
2 Numerator Instructions: Requirements for calculating the numerator include the following documentation in the pathologist/ dermopathologist s tracking system: Date tissue specimen received Date pathology report was sent to the biopsying clinician OR Numerator Options: Performance Met: Performance Not Met: Pathology report diagnosing cutaneous basal cell carcinoma or squamous cell carcinoma (to include in situ disease) sent from the Pathologist/Dermatopathologist to the biopsying clinician for review within 7 business days from the time when the tissue specimen was received by the pathologist (G9785) Pathology report diagnosing cutaneous basal cell carcinoma or squamous cell carcinoma (to include in situ disease) was not sent from the Pathologist/Dermatopathologist to the biopsying clinician for review within 7 business days from the time when the tissue specimen was received by the pathologist (G9786) RATIONALE: Effective communication through the biopsy report between pathologist and referring physician is essential; as delay may directly affect patient care. Furthermore, lack of timely delivery of results can increase the cost of medical care, error and the anxiety the patient experiences in waiting for results. This measure seeks to ensure timely communication and effective treatment for the patient. CLINICAL RECOMMENDATION STATEMENTS: [Pathology] reports should be issued in a timely manner. Failure to report results promptly may delay patient care (thus uselessly adding to the cost of medical care), [and] lead to error and confusion ( Holland Frei Cancer Medicine Vol. 8, 2010) COPYRIGHT: This Measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. This Measure, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. Commercial use of this measure requires a license agreement between the user and the American Academy of Dermatology (AAD). Neither the AAD nor its members shall be responsible for any use of the Measure. AAD encourages use of this Measure by other health care professionals, where appropriate. THE MEASURES AND SPECIFICATIONS ARE PROVIDED AS IS WITHOUT WARRANTY OF ANY KIND American Academy of Dermatology. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. 2 of 6
3 Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AAD and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT ) or other coding contained in the specifications. CPT contained in the Measures specifications is copyright American Medical Association. LOINC copyright Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT ) copyright College of American Pathologists. All Rights Reserved. 3 of 6
4 4 of 6
5 2017 Registry Individual Measure Flow #440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time Pathologist to Clinician Please refer to the specific section of the Measure Specification to identify the denominator and numerator information for use in reporting this Individual Measure. 1. Start with Denominator 2. Check Diagnosis: a. If Diagnosis of Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) as Listed in the Denominator equals No during the measurement period, do not include in Eligible Patient Population. Stop Processing. b. If Diagnosis of Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) as Listed in the Denominator equals Yes during the measurement period, proceed to check Patient Encounter. 3. Check Patient Encounter: a. If Patient Encounter as Listed in Denominator equals No, do not include in Eligible Patient Population. Stop Processing. b. If Patient Encounter as Listed in Denominator equals Yes, proceed to check Denominator Exclusion. 4. Check Denominator Exclusion, Pathologist /Dermatopathologist Providing a Second Opinion on a Biopsy: a. If Pathologist /Dermatopathologist Providing a Second Opinion on a Biopsy equals Yes, do not include in Eligible Patient Population. Stop Processing. b. If Pathologist /Dermatopathologist Providing a Second Opinion on a Biopsy equals No, include in Eligible Patient Population. 5. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d equals 8 procedures in the sample calculation. 6. Start Numerator 7. Check Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) sent by Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist: 5 of 6
6 a. If Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) sent by Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist equals Yes, include in Data Completeness Met and Performance Met. b. Data Completeness Met and Performance Met is represented as Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter a equals 4 procedures in the Sample Calculation. c. If Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) sent by Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist equals No, proceed to Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) was not sent to the Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist. 8. Check Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) was not sent to the Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist: a. If Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) was not sent to the Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist equals Yes, include in Data Completeness Met and Performance Not Met. b. Data Completeness Met and Performance Not Met is represented as Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter c equals 3 procedures in the Sample Calculation. c. If Pathology Report Diagnosing Cutaneous Basal Cell Carcinoma or Squamous Cell Carcinoma (to include in situ disease) was not sent to the Pathologist /Dermatopathologist to the Biopsying Clinician for review within 7 Business Days from the Time when the Tissue Specimen was Received by the Pathologist equals No, proceed to Data Completeness Not Met. 9. Check Data Completeness Not Met: a. If Data Completeness Not Met equals No, Quality Data Code or equivalent not reported. 1 procedure has been subtracted from the data completeness numerator in sample calculation. 6 of 6
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #143 (NQF 0384): Oncology: Medical and Radiation Pain Intensity Quantified National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2016 PQRS OPTIONS FOR INDIVIDUAL
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #337: Tuberculosis Prevention for Psoriasis,Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier National Quality Strategy Domain: Effective Clincal Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL
DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis
Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
Measure #145: Radiology: Exposure Time Reported for Procedures Using Fluoroscopy National Quality Strategy Domain: Patient Safety
Measure #145: Radiology: Exposure Time Reported for Procedures Using Fluoroscopy National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination Therapy National Quality Strategy Domain: Patient Safety
Measure #430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination Therapy National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care
Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence
Measure #50: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2016 PQRS
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU) National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS OPTIONS FOR
Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care
Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #218 (NQF 0423): Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS
Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care
Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of women 50
Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care
Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients
Physician Quality Reporting System (PQRS)
Physician Quality Reporting System (PQRS) and the Value-Based Payment Modifier Implementation guide for registry-based reporting for the Hepatitis C (HCV) Measures Group 2015 1 Overview of PQRS 1,2 What
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:
Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care
Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
Measure #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care
Measure #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Adult patients
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
CPT only copyright 2014 American Medical Association. All rights reserved. 10/10/2014 Page 537 of 593
Measure #391 (NQF 0576): Follow-Up After Hospitalization for Mental Illness (FUH) National Quality Strategy Domain: Communication and Care Coordination 2015 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:
Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety
Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Standardizing lab data to LOINC for meaningful use
Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Standardizing lab data to LOINC for meaningful use Executive summary By using standard terminologies to report on core
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery
Billing and Coding for Mohs Surgery Cindy L. Wilson Dermatology Associates of Tulsa Oklahoma Facts Per square mile, Oklahoma has more tornadoes than any other place in the world. The highest wind speed
* Dignity Health. Success
* Dignity Health. Tools for Success Table of Contents ICD 10 Overview Physician Practice Checklist Financial Planning for ICD 10 ICD 10 Education for Physicians ICD 10 Education for Staff ICD 10 Impacts
Below are some of the ways pathologists contribute to the six domains (listed in the order they appear on page 2 of the Strategy):
January 10, 2014 Center for Medicare and Medicaid Services U.S. Department of Health and Human Services 7500 Security Boulevard Baltimore, Maryland 21244-18559 Re: CMS Quality Strategy Submitted electronically
ICD-10-CM Training Module for Dental Practitioners. Presented by Workgroup for Electronic Data Interchange
ICD-10-CM Training Module for Dental Practitioners Presented by Workgroup for Electronic Data Interchange Disclaimer This presentation is for discussion and educational purposes only and is not intended
Reporting of Devices and Leads When a Credit is Received
Reporting of Devices and Leads When a Credit is Received Cardiac Rhythm Management and Electrophysiology Updated January 2014 Medicare Reporting Requirements For Full or Partial Credits of Devices and
White Paper Synoptic Reporting and Structured Data Capture
White Paper Synoptic Reporting and Structured Data Capture Business Case for Synoptic Reporting and Beyond Introduction The amount of clinically significant findings a surgical pathologist is expected
The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development:
The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development: Title: Non-Recommended PSA-Based Screening Description: The percentage
Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
2016 Physician Quality Reporting System (PQRS) Measure Specification and Measure Flow Guide for Claims and Registry Reporting of Individual Measures
2016 Physician Quality Reporting System (PQRS) Measure Specification and Measure Flow Guide for Claims and Registry Reporting of Individual Measures Utilized by Individual Eligible Professionals for Claims
Medical Association of Billers
Page 1 of 9 Certified Medical Billing Specialist (CMBS) Sample Examination Copyright of the. All rights reserved. No part of this sample exam may be reproduced or transmitted in any form or by any means,
TEST INSTRUCTIONS FOR CROSS VENDOR EXCHANGE TABLE OF CONTENTS
TEST INSTRUCTIONS FOR CROSS VENDOR EXCHANGE TABLE OF CONTENTS Introduction...2 Meaningful Use Objectives and Measures... 3 Eligible Professionals 495.6(j)(14)... 3 Eligible Hospitals and Critical Access
OECD Study of Electronic Health Record Systems
OECD Study of Electronic Health Record Systems Ministry of Health of the Czech Republic E health Expert Group Meeting 19 June 2012 Jillian Oderkirk OECD/HD Background and Needs The 2010 Health Ministerial
September 5, 2014. Linda Stewart Vice President, National Lab Program UnitedHealthcare Group P.O. Box 1459 Minneapolis, MN 55440 1459
September 5, 2014 Linda Stewart Vice President, National Lab Program UnitedHealthcare Group P.O. Box 1459 Minneapolis, MN 55440 1459 Re: UnitedHealthcare Laboratory Benefit Management Program Dear Ms.
Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers
Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers Terminology Management is a foundational element to satisfying the Meaningful Use Stage 2 criteria and due to its complexity, and
Is your medical management provider ready for ICD-10?
Is your medical management provider ready for ICD-10? ICD-10 codes will replace all current ICD-9 codes Customized solutions. Consultative partnerships. Healthy outcomes. What are ICD-10 codes? ICD-10-CM
Disclaimer CODING 101 BOOT CAMP CODING SEMINAR FOR NEW PHYSICIANS
CODING 101 BOOT CAMP CODING SEMINAR FOR NEW PHYSICIANS AND STAFF Chicago Dermatological Society January 26, 2013 Presented by Joy Newby, LPN, CPC, PCS Newby Consulting, Inc. 5725 Park Plaza Court Indianapolis,
The Big Picture: IDNT in Electronic Records Glossary
TERM DEFINITION CCI Canada Health Infoway Canadian Institute for Health Information EHR EMR EPR H L 7 (HL7) Canadian Classification of Interventions is the Canadian standard for classifying health care
Welcome to the Data Analytics Toolkit PowerPoint presentation on clinical quality measures, meaningful use, and data analytics.
Welcome to the Data Analytics Toolkit PowerPoint presentation on clinical quality measures, meaningful use, and data analytics. According to the Centers for Medicare and Medicaid Services, Clinical Quality
Preparing for the Conversion from ICD-9 to ICD-10: What You Need to Be Doing Today
Preparing for the Conversion from ICD-9 to ICD-10: What You Need to Be Doing Today Currently in the United States, ICD-9 is the code set used to report diagnoses and inpatient procedures. ICD-9 stands
Technology Assisting Cancer Outcomes: Automated Biomarker Abstraction Overcoming Textual Data-Silos
Technology Assisting Cancer Outcomes: Automated Biomarker Abstraction Overcoming Textual Data-Silos Patrick Mergler, MBA PMP CPHIMS DISCLAIMER: The views and opinions expressed in this presentation are
Stage 2 Public Health Core Objective. Eligible Professionals
To demonstrate meaningful use under Stage 2 criteria EPs must meet 17 core objectives and 3 menu objectives that they select from a list of 6, for a total of 20 objectives. As with the previous stage,
Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Enabling effective health information exchange
Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Enabling effective health information exchange Understanding health information exchanges (HIEs) What is the goal of
New Patient Visit. UnitedHealthcare Medicare Reimbursement Policy Committee
New Patient Visit Policy Number NPV04242013RP Approved By UnitedHealthcare Medicare Committee Current Approval Date 12/16/2015 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to
HIE Ready 2.0 SPECIFICATIONS MATRIX. Product Name: Version Number: Preferred Message and Trigger
HIE Ready 2.0 SPECIFICATIONS MATRIX Entity Name: Street Address: City, State, Zip: Point of Contact Name: E-mail & Phone: Alternate Contact Name: Alternate E-mail & Phone: Product Name: Version Number:
Electronic Health Record Systems and Secondary Data Use
Electronic Health Record Systems and Secondary Data Use HCQI Expert Group Meeting 10 May 2012 Jillian Oderkirk OECD/HD Background and Needs The 2010 Health Ministerial Communiqué noted that health care
Physical Therapy (PT) Modalities and Evaluation
Status Active Reimbursement Policy Section: Rehabilitative Services Policy Number: RP - Rehabilitative Services - 001 PT Modalities and Evaluation Effective Date: June 1, 2015 Physical Therapy (PT) Modalities
HEALTH DEPARTMENT BILLING GUIDELINES
HEALTH DEPARTMENT BILLING GUIDELINES Acknowledgement: Current Procedural Terminology (CPT ) is copyright 2015 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative
Physician Compare. Virtual Office Hour Session. January 22, 2015
Physician Compare Virtual Office Hour Session January 22, 2015 Alesia Hovatter Health Policy Analyst Division of Electronic and Clinician Quality Quality Measurement and Health Assessment Group Center
ICD-10 FROM A NURSE PERSPECTIVE. Learning Objectives 4/22/2015. Adoption of ICD-10 Classification of Diseases CD-10-CM Diagnostic Codes
ICD-10 FROM A NURSE PERSPECTIVE Learning Objectives 1. New ICD-10-CM diagnostic system for Dermatology. 2. Impact of new codes on nursing and clinical support staff. 3. Education and resources available.
Anthem Workers Compensation
Anthem Workers Compensation ICD-10 Frequently Asked Questions What is ICD-10? International Classification of Diseases, 10th Revision (ICD-10) is a diagnostic and procedure coding system endorsed by the
National Council for Behavioral Health
National Council for Behavioral Health Preparing your Organization for ICD-10 Implementation Presented by: Michael D. Flora, MBA, M.A.Ed, LCPC, LSW Senior Operations and Management Consultant David R.
Healthcare Market Overview
Healthcare Market Overview INTRODUCTION For healthcare organizations that require instantaneous availability of accurate information, mtuitive extends the value of legacy investments with capture and delivery
AvMed s Physician-to- Physician Referral Program
AvMed s Physician-to- Physician Referral Program Quick Reference Guide For Primary Care Physicians 1 P age Introduction Primary Care Physicians (PCPs) play a critical role in the health of our Medicare
Change is Coming in 2014! ICD-10 will replace ICD-9 for Diagnosis Coding
Change is Coming in 2014! ICD-10 will replace ICD-9 for Diagnosis Coding Clinical Coding Diagnosis Codes Clinicians select ICD-CM codes to describe a patient s diagnoses, symptoms, and clinical findings.
Problem-Centered Care Delivery
HOW INTERFACE TERMINOLOGY MAKES STANDARDIZED HEALTH INFORMATION POSSIBLE Terminologies ensure that the languages of medicine can be understood by both humans and machines. by June Bronnert, RHIA, CCS,
Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports
Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports W. Scott Campbell, Ph.D., MBA James R. Campbell, MD Acknowledgements Steven H. Hinrichs, MD Chairman
ICD-10 Overview. The U.S. Department of Health and Human Services implementation deadline for compliance with ICD-10, Mandate is October 1, 2014.
ICD-10 Overview ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization
Post-PET Restaging Cancer Form National Oncologic PET Registry
Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer
Corporate Overview. April 2014 OTCQB: LCDX
Corporate Overview April 2014 OTCQB: LCDX Company Snapshot biopsy Provides non-invasive, point-of-care cellular imaging technologies VivaScope systems can improve patient outcomes while reducing costs
What You Need to Know for the Upcoming Transition to ICD-10. Written by the AMA CPT Medical Informatics Department
What You Need to Know for the Upcoming Transition to ICD-10 Written by the AMA CPT Medical Informatics Department W H I T E P A P E R J U N E 2 0 1 2 This white paper is for educational purposes only and
Local Coverage Determination (LCD): Vitamin B 12 Injection (L33502)
Local Coverage Determination (LCD): Vitamin B 12 Injection (L33502) Contractor Name Noridian Administrative Services, LLC LCD Information Document Information LCD ID L33502 LCD Title Vitamin B 12 Injection
Summary of the Proposed Rule for the Medicare and Medicaid Electronic Health Records (EHR) Incentive Program (Eligible Professionals only)
Summary of the Proposed Rule for the Medicare and Medicaid Electronic Health Records (EHR) Incentive Program (Eligible Professionals only) Background Enacted on February 17, 2009, the American Recovery
Medical Terminologies and Classification Systems
CHAPTER 5 Medical Terminologies and Classification Systems Objectives After reading this chapter, you should be able to: Classify various medical nomenclatures Differentiate common classification systems
Introduction to ICD-10: A Guide for Providers. Centers for Medicare & Medicaid Services
Introduction to ICD-10: A Guide for Providers Centers for Medicare & Medicaid Services 1 Table of Contents Compliance Date: October 1, 2014» What is ICD-10?» Why ICD-10 matters» Why transition to ICD-10»
ductal carcinoma in situ (DCIS)
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding
Status Active. Assistant Surgeons. This policy addresses reimbursement for assistant surgical procedures during the same operative session.
Status Active Reimbursement Policy Section: Surgery/Interventional Procedure Policy Number: RP - Surgery/Interventional Procedure - 001 Assistant Surgeons Effective Date: June 1, 2015 Assistant Surgeons
Explanation of your PAP smear
Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,
Transitioning to ICD-10. Ready for October 1, 2014?
Transitioning to ICD-10 Ready for October 1, 2014? Time and tide wait for no man. Ready or not, ICD-10 is coming. Will you be ready? We will. The Georgia Department of Community Health (DCH) and Georgia
Local Coverage Article: Venipuncture Necessitating Physician s Skill for Specimen Collection Supplemental Instructions Article (A50852)
Local Coverage Article: Venipuncture Necessitating Physician s Skill for Specimen Collection Supplemental Instructions Article (A50852) Contractor Information Contractor Name CGS Administrators, LLC Article
Briefing on ehr Content Hong Kong Clinical Terminology Table (HKCTT) By Maggie LAU Health Informatician, ehriso
Briefing on ehr Content Hong Kong Clinical Terminology Table (HKCTT) By Maggie LAU Health Informatician, ehriso Agenda Background Application Adoption Management RecognisedTerminologies in ehr Registered
Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.
Skin Cancer: The Facts Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Types of skin Cancer Basal cell carcinoma (BCC) most common
Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC
Coding Dermatology Procedures Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC 1 No part of this presentation may be reproduced or transmitted in any form or by any means (graphically,
ICD-10-CM: Behavioral Health Providers
ICD-10-CM: Behavioral Health Providers DSM-5 Path to Success July and August 2015 ICD-10-CM: Behavioral Health Focus DSM-5* Supports the Behavioral Health Transition to ICD-10 Claim Submission Dates of
What is Data Analytics and How Does it Help Prepare Providers for ICD-10?
What is Data Analytics and How Does it Help Prepare Providers for ICD-10? June 2013 Kim Charland, BA, RHIT, CCS Senior Vice President of Clinical Consulting Services Panacea Healthcare Solutions, Inc.
QUALITY REPORTING. Zahid Butt MD,FACG October 22, 2010. 2007 Medisolv Inc.
QUALITY REPORTING Zahid Butt MD,FACG October 22, 2010 The Quality Landscape 100+ Entities Data Sources Claims / Administrative Mandatory Submission Voluntary Submission Other Databases Source: Society
Extracting Value from Secondary Uses of Electronic Health Data
Extracting Value from Secondary Uses of Electronic Health Data The Regenstrief Institute, Indianapolis Indiana Thomas S. Inui, ScM, MD President and CEO, Regenstrief Institute Associate Dean for Health
Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
ICD-10 FAQ. How Long Has ICD-9-CM Been In Use?
ICD-10 FAQ How Long Has ICD-9-CM Been In Use? What Code Set Does ICD-9-CM Define? What Code Set Does ICD-10 Define? When was ICD-10-CM Created? What agency maintains ICD-10? Why is ICD-10 better than ICD-9?
How to Conduct a Thorough CAC Readiness Assessment
WHITE PAPER How to Conduct a Thorough CAC Readiness Assessment A White Paper from Nuance Healthcare HEALTHCARE COMPUTER-ASSISTED CODING Contents Introduction... 3 The Benefits of CAC... 4 The New Role
CODING. Neighborhood Health Plan 1 Provider Payment Guidelines
CODING Policy The terms of this policy set forth the guidelines for reporting the provision of care rendered by NHP participating providers, including but not limited to use of standard diagnosis and procedure
Title: Coding Documentation for IHS Affiliated Physician Practices
Affiliated Physician Practices Effective Date: 11/03; Rev. 4/06, 7/08, 7/10 POLICY: IHS affiliated physician practices will code diagnoses utilizing the International Classification of Diseases, Ninth
Understanding your pathology report
Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What
Stage 2 EHR Certification: NLM Vocabulary Update. Betsy Humphreys Deputy Director, NLM
Stage 2 EHR Certification: NLM Vocabulary Update Betsy Humphreys Deputy Director, NLM Proposed Stage 2 certification criteria **SNOMED CT problem list *LOINC laboratory tests *RxNorm medications, med.
Best Practice Partnership Program
Best Practice Partnership Program Empowering Community- Based Pathologists Keeping Medicine Local Losing outreach to centralized reference laboratories? Wondering how molecular testing & digital pathology
Professional/Technical Component Policy
Policy Number 2015R0012C Professional/Technical Component Policy Annual Approval Date 1/27/2014 Approved By Payment Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are responsible
Innerview Reimbursement in the Physician Office Setting * 2014
OVERVIEW This Guide is intended to assist with the process of billing and coding for Innerview, a Mental Health Clinical Decision Support System used in the primary care setting. Billing, coding and payment
Frequently Asked Questions about ICD-10-CM/PCS
Frequently Asked Questions about ICD-10-CM/PCS Q: What is ICD-10-CM/PCS? A: ICD-10-CM (International Classification of Diseases -10 th Version-Clinical Modification) is designed for classifying and reporting
FAQs on Billing for Health and Behavior Services
FAQs on Billing for Health and Behavior Services by Government Relations Staff January 29, 2009 Practicing psychologists are eligible to bill for applicable services and receive reimbursement from Medicare
Oncology Medical Home Measure Specification Data
Oncology Medical Home Measure Specification Data Measure Name Chemotherapy pathway compliance Measure # 1 Measure Description % of chemotherapy treatments that have adhered to NCCN guidelines or pathways.
How To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
CRITICAL ILLNESS CLAIM FORM
Send all claims to: Continental American Insurance Company Critical Illness Claims Processing Unit Post Office Box 427 Columbia, South Carolina 29202 Phone: (800)-433-3036 Fax: (866)-849-2970 CRITICAL
Nebraska Cancer Registry Statutes
Nebraska Cancer Registry Statutes The following Nebraska statutes can be found on the website: http://uniweb.legislature.ne.gov/legaldocs/view.php?page=s81index The Nebraska Statutes pertaining to the
ICD-10-CM and ICD-10-PCS Frequently asked questions for HIM and Patient Financial Services Leaders
ICD-10-CM and ICD-10-PCS Frequently asked questions for HIM and Patient Financial Services Leaders Executive questions What is the current status of ICD-10? The U.S. Department of Health and Human Services